Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 10

1.

Isoprostanes and neuroprostanes as biomarkers of oxidative stress in neurodegenerative diseases.

Miller E, Morel A, Saso L, Saluk J.

Oxid Med Cell Longev. 2014;2014:572491. doi: 10.1155/2014/572491. Epub 2014 Apr 29.

PMID:
24868314
[PubMed - in process]
Free PMC Article
2.

Efficacy of antidotes (midazolam, atropine and HI-6) on nerve agent induced molecular and neuropathological changes.

RamaRao G, Afley P, Acharya J, Bhattacharya BK.

BMC Neurosci. 2014 Apr 4;15:47. doi: 10.1186/1471-2202-15-47.

PMID:
24708580
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Isoprostanes and 4-hydroxy-2-nonenal: markers or mediators of disease? Focus on Rett syndrome as a model of autism spectrum disorder.

Signorini C, De Felice C, Durand T, Oger C, Galano JM, Leoncini S, Pecorelli A, Valacchi G, Ciccoli L, Hayek J.

Oxid Med Cell Longev. 2013;2013:343824. doi: 10.1155/2013/343824. Epub 2013 Jun 13. Review.

PMID:
23844273
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Chlorpyrifos-, diisopropylphosphorofluoridate-, and parathion-induced behavioral and oxidative stress effects: are they mediated by analogous mechanisms of action?

López-Granero C, Cañadas F, Cardona D, Yu Y, Giménez E, Lozano R, Avila DS, Aschner M, Sánchez-Santed F.

Toxicol Sci. 2013 Jan;131(1):206-16. doi: 10.1093/toxsci/kfs280. Epub 2012 Sep 17.

PMID:
22986948
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Characterization of status epilepticus induced by two organophosphates in rats.

Todorovic MS, Cowan ML, Balint CA, Sun C, Kapur J.

Epilepsy Res. 2012 Sep;101(3):268-76. doi: 10.1016/j.eplepsyres.2012.04.014. Epub 2012 May 9.

PMID:
22578704
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Functional consequences of repeated organophosphate exposure: potential non-cholinergic mechanisms.

Terry AV Jr.

Pharmacol Ther. 2012 Jun;134(3):355-65. doi: 10.1016/j.pharmthera.2012.03.001. Epub 2012 Mar 20. Review.

PMID:
22465060
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

A review of experimental evidence linking neurotoxic organophosphorus compounds and inflammation.

Banks CN, Lein PJ.

Neurotoxicology. 2012 Jun;33(3):575-84. doi: 10.1016/j.neuro.2012.02.002. Epub 2012 Feb 10. Review.

PMID:
22342984
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Protective effects of antioxidants and anti-inflammatory agents against manganese-induced oxidative damage and neuronal injury.

Milatovic D, Gupta RC, Yu Y, Zaja-Milatovic S, Aschner M.

Toxicol Appl Pharmacol. 2011 Nov 1;256(3):219-26. doi: 10.1016/j.taap.2011.06.001. Epub 2011 Jun 13.

PMID:
21684300
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Reaction of cresyl saligenin phosphate, the organophosphorus agent implicated in aerotoxic syndrome, with human cholinesterases: mechanistic studies employing kinetics, mass spectrometry, and X-ray structure analysis.

Carletti E, Schopfer LM, Colletier JP, Froment MT, Nachon F, Weik M, Lockridge O, Masson P.

Chem Res Toxicol. 2011 Jun 20;24(6):797-808. doi: 10.1021/tx100447k. Epub 2011 Apr 18.

PMID:
21438623
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Morphometric analysis in neurodegenerative disorders.

Milatovic D, Montine TJ, Zaja-Milatovic S, Madison JL, Bowman AB, Aschner M.

Curr Protoc Toxicol. 2010 Feb;Chapter 12:Unit 12.16. doi: 10.1002/0471140856.tx1216s43.

PMID:
20401325
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk